Lastly, lysine deficiency was able to overcome the resistance of EGFR-TKIs and vigorously reduced cell survival under a combination of osimertinib-treatment in EGFR-mutant NSCLC cells. This evidence concerns the gene EGFR and non-small cell lung carcinoma.